| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |